Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9

Site-specific modification of antibodies has become a critical aspect in the development of next-generation immunoconjugates meeting criteria of clinically acceptable homogeneity, reproducibility, efficacy, ease of manufacturability, and cost-effectiveness. Using CRISPR/Cas9 genomic editing, we deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Khoshnejad, Makan, Brenner, Jacob S., Motley, William, Parhiz, Hamideh, Greineder, Colin F., Villa, Carlos H., Marcos-Contreras, Oscar A., Tsourkas, Andrew, Muzykantov, Vladimir R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789018/
https://www.ncbi.nlm.nih.gov/pubmed/29379029
http://dx.doi.org/10.1038/s41598-018-19784-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789018/
https://www.ncbi.nlm.nih.gov/pubmed/29379029
http://dx.doi.org/10.1038/s41598-018-19784-2

Ejemplares similares